|
|
 |
UK Business
Experience
|
|
Biotechnology and pharmaceutical
The Technology Division has worked with many of the large pharmaceutical companies and, in particular, was involved in the delivery and validation of Wyeth’s $1.2 billion world-class biopharma campus in Dublin in joint venture with Jacobs Engineering. The business continues to work alongside Wyeth.
We are proud to have worked in partnership with GlaxoSmithKline (GSK) as one of its preferred suppliers for over five years and, previously, with SmithKlineBeecham, for over 20 years. This relationship has spanned all elements of GSK’s business from research and development through to manufacturing. Globally, Bovis Lend Lease has carried out commissions on over 30 GSK sites in some 12 countries across various parts of the GSK network.
The most recently completed project, H35 at Harlow, has been hailed as a great success as it not only provided GSK with a world-class innovative facility but also finished ahead of programme and under budget. The Technology Division worked with GSK in challenging its normal working practices. Modular, standardised elements of ‘fabric’ and equipment were introduced that helped to speed up the delivery process as well as provided greater flexibility for reconfiguration than more traditional laboratory design. The innovative design also brought significant life cycle benefits.
Healthcare
The Technology Division services a number of clients in the healthcare sector as well as provides in-house support to project teams delivering PFI hospital schemes around the UK.
Completed earlier this year, the Cheshire and Merseyside NHS Treatment Centre in the grounds of Halton General Hospital near Runcorn specialises in orthopaedic treatments. This new 6,700 square metre, three-storey building is managed on behalf of the NHS by independent sector provider, Interhealth Care Services (UK) Limited, and was designed and constructed by the Technology Division in 14 months.
Our relationship with the healthcare sector does not focus purely on design and delivery, but also covers a range of consultancy services including integrated commissioning and validation, regulatory compliance, feasibility studies and concept studies. Past and present clients include the National Blood Service, Barts and the London NHS Trust, Moorfields Eye Hospital, GSK, Pfizer and Wyeth. In particular, we have a commendable track record in supporting NHS Pharmaceutical Manufacturing Units, maintaining regulatory compliance and equipping and validating new facilities.
Food and beverage
The Technology Division has long undertaken projects for clients from a range of process-driven industries including food, personal hygiene, microelectronics, chemicals and manufacturing.
We have completed the design, engineering, procurement and construction management of a 7,500 square metre gum base manufacturing facility in Ireland for Cadbury Schweppes, and two others are currently under construction, one in the UK and one in Poland, with a total value of over £90 million. The new 5,000 square metre facility at Pontefract, West Yorkshire, for Cadbury’s subsidiary, Monkhill Confectionery, is being constructed on the site of a building completely destroyed by fire in June 2005 while the new 42,000 square metre chewing gum factory on a Greenfield site in Wroclaw will be Cadbury’s second factory in the city and its third in Poland with another in Warsaw. The new factory is the largest investment in the food sector in Poland over the last ten years.
Industrial
The Technology Division has a long-standing relationship with BPB British Gypsum and is nearing the completion of two plasterboard manufacturing facilities in the UK, one in Sherburn and one in East Leake. With a combined value of over £120 million, they form part of an ongoing investment programme by British Gypsum and will feature leading edge technology and best practice from more than 40 plasterboard plants across the globe.
Sherburn will be the first all-new plasterboard manufacturing facility to be built in the UK for more than 15 years and will increase British Gypsum’s current plasterboard capacity by around 20 per cent. At East Leake, we are managing the construction of a third plaster manufacturing plant on the site as well as modernising and re-equipping the mine that continues to supply gypsum for the manufacture of the plasterboard.
Technology
Experience within the technology sector has ranged from the design and delivery of micro-electronics facilities, including a recently completed 8,000 square metre plant manufacturing the next generation of semi-conductors, to the design and delivery of high-tech laboratories for research and development.
At present we are working with the University of Southampton to rebuild the Mountbatten building which was destroyed by fire in November 2005. The new facility will accommodate research laboratories and offices for the university’s School of Electronics and Computer Science and Optoelectronics Research Centre. The new reinforced concrete framed building will house clean rooms containing specialist microelectronics production tools and optical laser equipment as well as technical laboratories, research areas and offices. Complex mechanical and electrical services will be installed to provide the necessary stable environmental conditions within the clean rooms.
|